Articles with "gus" as a keyword



Development of a VP28-pseudotyped baculovirus expression system for efficient gene transfer in penaeid shrimps

Sign Up to like & get
recommendations!
Published in 2021 at "Aquaculture"

DOI: 10.1016/j.aquaculture.2021.736741

Abstract: Abstract Both efficient gene transfer and expression tools and suitable reporter genes are lacking for penaeid shrimps and their isolated cells. In this study a VP28-pseudotyped insect baculovirus expression system: Bacmid-GUS/VP28, carrying a reporter gene… read more here.

Keywords: expression; vp28; gene; gene transfer ... See more keywords

Discovery and Characterization of FMN-Binding β-Glucuronidases in the Human Gut Microbiome.

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of molecular biology"

DOI: 10.1016/j.jmb.2019.01.013

Abstract: The human gut microbiota encodes β-glucuronidases (GUSs) that play key roles in health and disease via the metabolism of glucuronate-containing carbohydrates and drugs. Hundreds of putative bacterial GUS enzymes have been identified by metagenomic analysis… read more here.

Keywords: gus; human gut; fmn binding; site ... See more keywords

A New Fluorescent Probe Tool: ERNathG.

Sign Up to like & get
recommendations!
Published in 2023 at "Analytical chemistry"

DOI: 10.1021/acs.analchem.3c00075

Abstract: β-d-Glucuronidase (GUS) plays a pivotal role in both clinical treatment assessment and environmental monitoring. Existing tools for GUS detection suffer from (1) poor continuity due to a gap between the optimal pH of the probes… read more here.

Keywords: gus; probe tool; fluorescent probe; new fluorescent ... See more keywords

Metagenomics combined with activity-based proteomics point to gut bacterial enzymes that reactivate mycophenolate

Sign Up to like & get
recommendations!
Published in 2022 at "Gut Microbes"

DOI: 10.1080/19490976.2022.2107289

Abstract: ABSTRACT Mycophenolate mofetil (MMF) is an important immunosuppressant prodrug prescribed to prevent organ transplant rejection and to treat autoimmune diseases. MMF usage, however, is limited by severe gastrointestinal toxicity that is observed in approximately 45%… read more here.

Keywords: mycophenolate; enzymes reactivate; gus; activity based ... See more keywords

Vancomycin relieves tacrolimus-induced hyperglycemia by eliminating gut bacterial beta-glucuronidase enzyme activity

Sign Up to like & get
recommendations!
Published in 2024 at "Gut Microbes"

DOI: 10.1080/19490976.2024.2310277

Abstract: ABSTRACT Up to 40% of transplant recipients treated long-term with tacrolimus (TAC) develop post-transplant diabetes mellitus (PTDM). TAC is an important risk factor for PTDM, but is also essential for immunosuppression after transplantation. Long-term TAC… read more here.

Keywords: beta glucuronidase; tac; gus; bacterial beta ... See more keywords

OP33 Efficacy and safety of subcutaneous guselkumab induction therapy in patients with moderately to severely active Crohn’s disease: Results through Week 48 from the phase 3 GRAVITI study

Sign Up to like & get
recommendations!
Published in 2025 at "Journal of Crohn's and Colitis"

DOI: 10.1093/ecco-jcc/jjae190.0033

Abstract: Guselkumab (GUS) is a dual-acting IL-23p19 subunit inhibitor that was efficacious in phase 3 trials (GALAXI 2/3) of pts with CD using IV induction and SC maintenance. We evaluated the efficacy and safety of GUS… read more here.

Keywords: history; maintenance; gus; safety ... See more keywords

P0669 Safety of intravenous and subcutaneous guselkumab induction administration: Results from the GALAXI and GRAVITI studies in participants with Crohn’s Disease

Sign Up to like & get
recommendations!
Published in 2025 at "Journal of Crohn's and Colitis"

DOI: 10.1093/ecco-jcc/jjae190.0843

Abstract: Guselkumab (GUS) is a dual-acting IL-23 inhibitor that potently neutralizes IL-23 and binds to CD64, a receptor on cells that produce IL-23. Induction with both intravenous (IV) and subcutaneous (SC) GUS was effective in phase… read more here.

Keywords: group; gus; induction period; safety ... See more keywords

Outage Analysis of IRS-Assisted UAV NOMA Downlink Wireless Networks

Sign Up to like & get
recommendations!
Published in 2024 at "IEEE Internet of Things Journal"

DOI: 10.1109/jiot.2023.3323311

Abstract: This article studies an intelligent reflecting surface (IRS)-assisted unmanned aerial vehicle (UAV) network, where the ground users (GUs) desire to receive information from a UAV. Downlink nonorthogonal multiple access (NOMA) is considered typically with two… read more here.

Keywords: based protocol; noma; outage; gus ... See more keywords

Microbial β-glucuronidases drive human periodontal disease etiology

Sign Up to like & get
recommendations!
Published in 2023 at "Science Advances"

DOI: 10.1126/sciadv.adg3390

Abstract: Periodontitis is a chronic inflammatory disease associated with persistent oral microbial dysbiosis. The human β-glucuronidase (GUS) degrades constituents of the periodontium and is used as a biomarker for periodontitis severity. However, the human microbiome also… read more here.

Keywords: microbial glucuronidases; disease; periodontal disease; etiology ... See more keywords

AB0772 EFFICACY OF GUSELKUMAB IN PSORIASIS PATIENTS WITH SELF-REPORTED PSORIATIC ARTHRITIS WITH INVOLVEMENT OF THE SCALP, NAILS, HANDS, AND FEET: A POOLED ANALYSIS FROM 2 PIVOTAL PHASE 3 PSORIASIS STUDIES

Sign Up to like & get
recommendations!
Published in 2019 at "Annals of the Rheumatic Diseases"

DOI: 10.1136/annrheumdis-2019-eular.183

Abstract: Background VOYAGE 1 & 2 were the pivotal Ph3 GUS trials for plaque psoriasis (PsO).1,2 Objectives Here we compare efficacy of GUS vs PBO & vs adalimumab (ADA) on PsO involving scalp, nail & palmoplantar… read more here.

Keywords: gus; pso; pga; psoriasis ... See more keywords

β-Glucuronidase Pattern Predicted From Gut Metagenomes Indicates Potentially Diversified Pharmacomicrobiomics

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Microbiology"

DOI: 10.3389/fmicb.2022.826994

Abstract: β-glucuronidases (GUS) of intestinal bacteria remove glucuronic acid from glucoronides, reversing phase II metabolism of the liver and affecting the level of active deconjugated metabolites deriving from drugs or xenobiotics. Two hundred seventy-nine non-redundant GUS… read more here.

Keywords: gus; gut metagenomes; pattern predicted; glucuronidase pattern ... See more keywords